Last 12 months
Inside the activity.
0 purchase rows · 5 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 08, 2022 Filed Mar 9, 2022 23:02 UTC |
Bonello WilliamChief Financial Officer
|
Exercise / conversionCommon Stock | 5,000 | $7.52 | $37,600.00 |
DisclosureSEC source: 0001077183-22-000049 · wf-form4_164686693130490.xml · nonDerivative · entry 2 Bonello William · CIK 0001454941 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,516 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 23:02 UTC |
Bonello WilliamChief Financial Officer
|
SaleCommon Stock | 3,209 | $18.29 | $58,692.61 |
DisclosureSEC source: 0001077183-22-000049 · wf-form4_164686693130490.xml · nonDerivative · entry 1 Bonello William · CIK 0001454941 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,516 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 00:58 UTC |
Dieter Cynthia JChief Accounting Officer
|
Tax withholdingCommon Stock | 137 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-22-000042 · wf-form4_164635549679223.xml · nonDerivative · entry 2 Dieter Cynthia J · CIK 0001815335 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,637 F2 · shares: Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 2, 2022 vesting of restricted stock. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 00:58 UTC |
CARDOZA GEORGEPresident & COO, Lab Ops
|
Tax withholdingCommon Stock | 839 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-22-000041 · wf-form4_164635544947414.xml · nonDerivative · entry 3 CARDOZA GEORGE · CIK 0001518734 · President & COO, Lab Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 244,157 F2 · shares: Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 2, 2022 vesting of restricted stock. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 00:57 UTC |
Bonello WilliamChief Financial Officer
|
Tax withholdingCommon Stock | 620 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-22-000040 · wf-form4_164635542516942.xml · nonDerivative · entry 3 Bonello William · CIK 0001454941 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,725 F3 · shares: Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 2, 2022 vesting of restricted stock. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 00:57 UTC |
Brown Douglas MatthewChief Strategy Officer
|
Tax withholdingCommon Stock | 867 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-22-000039 · wf-form4_164635540556006.xml · nonDerivative · entry 2 Brown Douglas Matthew · CIK 0001849414 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,379 F2 · shares: Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 2, 2022 vesting of restricted stock. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 00:59 UTC |
Gilbert Halley EChief Legal Officer
|
GrantStock Option (Right to Buy) · Derivative | 102,623 | $0.00 Strike: $21.41 | $0.00 |
DisclosureSEC source: 0001077183-22-000044 · wf-form4_164635555368681.xml · derivative · entry 3 Gilbert Halley E · CIK 0001601360 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,623 Underlying: Common Stock · 102,623 shares Expires 2029-03-01 F4 · derivative.exercise_date: On March 1, 2022, Ms. Gilbert was granted 102,623 stock options. These options vest ratably over the first four anniversary dates of the grant date. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 00:59 UTC |
Gilbert Halley EChief Legal Officer
|
GrantCommon Stock | 42,036 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-22-000044 · wf-form4_164635555368681.xml · nonDerivative · entry 1 Gilbert Halley E · CIK 0001601360 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,396 F1 · shares: On March 1, 2022, Ms. Gilbert was granted 42,036 restricted stock awards. These awards vest ratably over the first four anniversary dates of the grant date. F2 · balance_after: This balance includes 97 shares that were acquired at a price of $19.16 per share pursuant to NeoGenomics's Employee Stock Purchase Plan (ESPP) during the month ended January 31, 2022. The shares were acquired in transactions exempt from Section 16b-3. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 00:59 UTC |
Mallon MarkDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 347,777 | $0.00 Strike: $21.41 | $0.00 |
DisclosureSEC source: 0001077183-22-000043 · wf-form4_164635552579023.xml · derivative · entry 3 Mallon Mark · CIK 0001763533 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 347,777 Underlying: Common Stock · 347,777 shares Expires 2029-03-01 F3 · derivative.exercise_date: On March 1, 2022, Mr. Mallon was granted 347,777 stock options. These options vest ratably over the first four anniversary dates of the grant date. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 00:59 UTC |
Mallon MarkDirector · Chief Executive Officer
|
GrantCommon Stock | 142,457 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-22-000043 · wf-form4_164635552579023.xml · nonDerivative · entry 1 Mallon Mark · CIK 0001763533 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 368,051 F1 · shares: On March 1, 2022, Mr. Mallon was granted 142,457 restricted stock awards. These awards vest ratably over the first four anniversary dates of the grant date. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 00:58 UTC |
Dieter Cynthia JChief Accounting Officer
|
GrantStock Option (Right to Buy) · Derivative | 22,805 | $0.00 Strike: $21.41 | $0.00 |
DisclosureSEC source: 0001077183-22-000042 · wf-form4_164635549679223.xml · derivative · entry 5 Dieter Cynthia J · CIK 0001815335 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,805 Underlying: Common Stock · 22,805 shares Expires 2029-03-01 F5 · derivative.exercise_date: On March 1, 2022, Ms. Dieter was granted 22,805 stock options. These options vest ratably over the first four anniversary dates of the grant date. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 00:58 UTC |
Dieter Cynthia JChief Accounting Officer
|
GrantCommon Stock | 9,341 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-22-000042 · wf-form4_164635549679223.xml · nonDerivative · entry 1 Dieter Cynthia J · CIK 0001815335 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,774 F1 · shares: On March 1, 2022, Ms. Dieter was granted 9,341 restricted stock awards. These awards vest ratably over the first four anniversary dates of the grant date. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 00:58 UTC |
CARDOZA GEORGEPresident & COO, Lab Ops
|
Tax withholdingCommon Stock | 503 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-22-000041 · wf-form4_164635544947414.xml · nonDerivative · entry 2 CARDOZA GEORGE · CIK 0001518734 · President & COO, Lab Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 244,996 F1 · shares: Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 1, 2022 vesting of restricted stock. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 00:57 UTC |
Bonello WilliamChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 99,772 | $0.00 Strike: $21.41 | $0.00 |
DisclosureSEC source: 0001077183-22-000040 · wf-form4_164635542516942.xml · derivative · entry 9 Bonello William · CIK 0001454941 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,772 Underlying: Common Stock · 99,772 shares Expires 2029-03-01 F9 · derivative.exercise_date: On March 1, 2022, Mr. Bonello was granted 99,772 stock options. These options vest ratably over the first four anniversary dates of the grant date. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 00:57 UTC |
Bonello WilliamChief Financial Officer
|
Tax withholdingCommon Stock | 397 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-22-000040 · wf-form4_164635542516942.xml · nonDerivative · entry 2 Bonello William · CIK 0001454941 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,345 F2 · shares: Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 1, 2022 vesting of restricted stock. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 00:57 UTC |
Bonello WilliamChief Financial Officer
|
GrantCommon Stock | 40,869 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-22-000040 · wf-form4_164635542516942.xml · nonDerivative · entry 1 Bonello William · CIK 0001454941 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,742 F1 · shares: On March 1, 2022, Mr. Bonello was granted 40,869 restricted stock awards. These awards vest ratably over the first four anniversary dates of the grant date. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 00:57 UTC |
Brown Douglas MatthewChief Strategy Officer
|
GrantStock Option (Right to Buy) · Derivative | 85,519 | $0.00 Strike: $21.41 | $0.00 |
DisclosureSEC source: 0001077183-22-000039 · wf-form4_164635540556006.xml · derivative · entry 5 Brown Douglas Matthew · CIK 0001849414 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,519 Underlying: Common Stock · 85,519 shares Expires 2029-03-01 F5 · derivative.exercise_date: On March 1, 2022, Mr. Brown was granted 85,519 stock options. These options vest ratably over the first four anniversary dates of the grant date. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 00:57 UTC |
Brown Douglas MatthewChief Strategy Officer
|
GrantCommon Stock | 35,030 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-22-000039 · wf-form4_164635540556006.xml · nonDerivative · entry 1 Brown Douglas Matthew · CIK 0001849414 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,246 F1 · shares: On March 1, 2022, Mr. Brown was granted 35,030 restricted stock awards. These awards vest ratably over the first four anniversary dates of the grant date. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 00:56 UTC |
Wallar Gina MPresident, Pharma Services
|
GrantStock Option (Right to Buy) · Derivative | 28,506 | $0.00 Strike: $21.41 | $0.00 |
DisclosureSEC source: 0001077183-22-000038 · wf-form4_164635538738847.xml · derivative · entry 8 Wallar Gina M · CIK 0001869819 · President, Pharma Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,506 Underlying: Common Stock · 28,506 shares Expires 2029-03-01 F9 · derivative.exercise_date: On March 1, 2022, Ms. Wallar was granted 28,506 stock options. These options vest ratably over the first four anniversary dates of the grant date. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 00:56 UTC |
Wallar Gina MPresident, Pharma Services
|
GrantCommon Stock | 11,677 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-22-000038 · wf-form4_164635538738847.xml · nonDerivative · entry 1 Wallar Gina M · CIK 0001869819 · President, Pharma Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,443 F1 · shares: On March 1, 2022, Ms. Wallar was granted 11,677 restricted stock awards. These awards vest ratably over the first four anniversary dates of the grant date. F2 · balance_after: This balance includes 104 shares that were acquired at a price of $19.16 per share pursuant to NeoGenomics's Employee Stock Purchase Plan (ESPP) during the month ended January 31, 2022. The shares wereacquired in transactions exempt from Section 16b-3. Read SEC document |
| January 11, 2022 Filed Jan 12, 2022 23:50 UTC |
McKenzie Kathryn BChief Sustainability/Risk Ofcr
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,100 | $0.00 Strike: $9.07 | $0.00 |
DisclosureSEC source: 0001077183-22-000002 · wf-form4_164203142741919.xml · derivative · entry 2 McKenzie Kathryn B · CIK 0001720001 · Chief Sustainability/Risk Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,900 Underlying: Common Stock · 2,100 shares Expires 2022-10-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On October 17, 2017, Ms. McKenzie was granted 25,000 stock options. These options vested ratably over the first three anniversary dates of the grant date. Read SEC document |
| January 11, 2022 Filed Jan 12, 2022 23:50 UTC |
McKenzie Kathryn BChief Sustainability/Risk Ofcr
|
Exercise / conversionCommon Stock | 2,100 | $9.07 | $19,047.00 |
DisclosureSEC source: 0001077183-22-000002 · wf-form4_164203142741919.xml · nonDerivative · entry 1 McKenzie Kathryn B · CIK 0001720001 · Chief Sustainability/Risk Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,361 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 31, 2021 Filed Feb 9, 2022 00:12 UTC |
Gilbert Halley EChief Legal Officer
|
OtherCommon Stock | 177 | $31.30 | $5,540.10 |
DisclosureSEC source: 0001077183-22-000009 · wf-form5_164436554542544.xml · nonDerivative · entry 1 Gilbert Halley E · CIK 0001601360 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,263 F1 · kind: These shares were acquired pursuant to NeoGenomics's Employee Stock Purchase Plan (ESPP) during the year ended December 31, 2021. The shares were acquired in transactions exempt from Section 16b-3. Read SEC document |
| December 31, 2021 Filed Feb 9, 2022 00:12 UTC |
Wallar Gina MPresident, Pharma Services
|
OtherCommon Stock | 363 | $35.28 | $12,806.64 |
DisclosureSEC source: 0001077183-22-000008 · wf-form5_164436552625449.xml · nonDerivative · entry 1 Wallar Gina M · CIK 0001869819 · President, Pharma Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,662 F1 · kind: These shares were acquired pursuant to NeoGenomics's Employee Stock Purchase Plan (ESPP) during the year ended December 31, 2021. The shares were acquired in transactions exempt from Section 16b-3. Read SEC document |
| December 30, 2021 Filed Dec 30, 2021 23:04 UTC |
McKenzie Kathryn BChief Financial Officer
|
GrantCommon Stock | 30,572 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-21-000276 · wf-form4_164090544806977.xml · nonDerivative · entry 1 McKenzie Kathryn B · CIK 0001720001 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,261 F1 · kind: On December 30, 2021, Ms. McKenzie was granted 30,572 restricted stock awards. These awards vest ratably over three years with the first tranche vesting on December 31, 2022. Read SEC document |
| December 30, 2021 Filed Dec 30, 2021 23:04 UTC |
CARDOZA GEORGEPresident & COO, Lab Ops
|
GrantCommon Stock | 61,143 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-21-000277 · wf-form4_164090546675301.xml · nonDerivative · entry 2 CARDOZA GEORGE · CIK 0001518734 · President & COO, Lab Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,499 F1 · kind: On December 30, 2021, Mr. Cardoza was granted 61,143 restricted stock awards. These awards vest ratably over three years with the first tranche vesting on December 31, 2022. Read SEC document |
| December 30, 2021 Filed Dec 30, 2021 23:03 UTC |
BALLIET JENNIFERVP and Chief Culture Officer
|
GrantCommon Stock | 21,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-21-000274 · wf-form4_164090540384967.xml · nonDerivative · entry 1 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,615 F1 · kind: On December 30, 2021, Ms. Balliet was granted 21,400 restricted stock awards. These awards vest ratably over three years with the first tranche vesting on December 31, 2022. Read SEC document |
| December 30, 2021 Filed Dec 30, 2021 23:05 UTC |
Wallar Gina MPresident, Pharma Services
|
GrantCommon Stock | 15,286 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-21-000280 · wf-form4_164090552671834.xml · nonDerivative · entry 1 Wallar Gina M · CIK 0001869819 · President, Pharma Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,299 F1 · kind: On December 30, 2021, Ms. Wallar was granted 15,286 restricted stock awards. These awards vest ratably over three years with the first tranche vesting on December 31, 2022. Read SEC document |
| December 30, 2021 Filed Dec 30, 2021 23:05 UTC |
Morris ClivePresident of Inivata
|
GrantCommon Stock | 30,572 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-21-000279 · wf-form4_164090550666107.xml · nonDerivative · entry 1 Morris Clive · CIK 0001869893 · President of Inivata 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,280 F1 · kind: On December 30, 2021, Mr. Morris was granted 30,572 restricted stock awards. These awards vest ratably over three years with the first tranche vesting on December 31, 2022. Read SEC document |
| December 30, 2021 Filed Dec 30, 2021 23:05 UTC |
Mallon MarkDirector · Chief Executive Officer
|
GrantCommon Stock | 152,858 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-21-000278 · wf-form4_164090548763134.xml · nonDerivative · entry 1 Mallon Mark · CIK 0001763533 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,594 F1 · kind: On December 30, 2021, Mr. Mallon was granted 152,858 restricted stock awards. These awards vest ratably over three years with the first tranche vesting on December 31, 2022. Read SEC document |
| December 30, 2021 Filed Dec 30, 2021 23:04 UTC |
Bonello WilliamPresident, Informatics
|
GrantCommon Stock | 21,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-21-000275 · wf-form4_164090542876784.xml · nonDerivative · entry 1 Bonello William · CIK 0001454941 · President, Informatics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,873 F1 · kind: On December 30, 2021, Mr. Bonello was granted 21,400 restricted stock awards. These awards vest ratably over three years with the first tranche vesting on December 31, 2022. Read SEC document |
| December 30, 2021 Filed Dec 30, 2021 23:03 UTC |
Dieter Cynthia JChief Accounting Officer
|
GrantCommon Stock | 7,643 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-21-000273 · wf-form4_164090538346827.xml · nonDerivative · entry 1 Dieter Cynthia J · CIK 0001815335 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,433 F1 · kind: On December 30, 2021, Ms. Dieter was granted 7,643 restricted stock awards. These awards vest ratably over three years with the first tranche vesting on December 31, 2022. Read SEC document |
| December 30, 2021 Filed Dec 30, 2021 23:02 UTC |
Gilbert Halley EChief Legal Officer
|
GrantCommon Stock | 45,858 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-21-000272 · wf-form4_164090535269636.xml · nonDerivative · entry 1 Gilbert Halley E · CIK 0001601360 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,086 F1 · kind: On December 30, 2021, Ms. Gilbert was granted 45,858 restricted stock awards. These awards vest ratably over three years with the first tranche vesting on December 31, 2022. Read SEC document |
| December 30, 2021 Filed Dec 30, 2021 23:02 UTC |
Brown Douglas MatthewChief Strategy Officer
|
GrantCommon Stock | 30,572 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-21-000271 · wf-form4_164090533233635.xml · nonDerivative · entry 1 Brown Douglas Matthew · CIK 0001849414 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,216 F1 · kind: On December 30, 2021, Mr. Brown was granted 30,572 restricted stock awards. These awards vest ratably over three years with the first tranche vesting on December 31, 2022. Read SEC document |
| December 22, 2021 Filed Dec 23, 2021 22:25 UTC |
McKenzie Kathryn BChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $9.07 | $0.00 |
DisclosureSEC source: 0001077183-21-000260 · wf-form4_164029831264611.xml · derivative · entry 3 McKenzie Kathryn B · CIK 0001720001 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 5,000 shares Expires 2022-10-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · derivative.exercise_date: On October 17, 2017, Ms. McKenzie was granted 25,000 stock options. These options vested ratably over the first three anniversary dates of the grant date Read SEC document |
| December 22, 2021 Filed Dec 23, 2021 22:25 UTC |
McKenzie Kathryn BChief Financial Officer
|
Exercise / conversionCommon Stock | 5,000 | $9.07 | $45,350.00 |
DisclosureSEC source: 0001077183-21-000260 · wf-form4_164029831264611.xml · nonDerivative · entry 2 McKenzie Kathryn B · CIK 0001720001 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,689 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 22, 2021 Filed Dec 23, 2021 22:25 UTC |
Johnson Kevin CDirector
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 3,334 | $0.00 Strike: $7.27 | $0.00 |
DisclosureSEC source: 0001077183-21-000259 · wf-form4_164029829717239.xml · derivative · entry 2 Johnson Kevin C · CIK 0001353436 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,334 shares Expires 2022-05-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On May 25, 2017, Mr. Johnson was granted 10,000 stock options. The options vested ratably over the first three anniversary dates of the grant date. Read SEC document |
| December 22, 2021 Filed Dec 23, 2021 22:25 UTC |
Johnson Kevin CDirector
|
Exercise / conversionCommon Stock | 3,334 | $7.27 | $24,238.18 |
DisclosureSEC source: 0001077183-21-000259 · wf-form4_164029829717239.xml · nonDerivative · entry 1 Johnson Kevin C · CIK 0001353436 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,398 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 21, 2021 Filed Dec 23, 2021 22:25 UTC |
McKenzie Kathryn BChief Financial Officer
|
SaleCommon Stock | 1,846 | $35.00 | $64,610.00 |
DisclosureSEC source: 0001077183-21-000260 · wf-form4_164029831264611.xml · nonDerivative · entry 1 McKenzie Kathryn B · CIK 0001720001 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,689 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 06, 2021 Filed Dec 6, 2021 21:16 UTC |
Mallon MarkDirector · Chief Executive Officer
|
PurchaseCommon Stock | 17,000 | $30.63 | $520,710.00 |
DisclosureSEC source: 0001077183-21-000256 · wf-form4_163882538985808.xml · nonDerivative · entry 1 Mallon Mark · CIK 0001763533 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,736 Read SEC document |
| November 30, 2021 Filed Dec 2, 2021 23:09 UTC |
Bonello WilliamPresident, Informatics
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $7.52 | $0.00 |
DisclosureSEC source: 0001077183-21-000254 · wf-form4_163848655622024.xml · derivative · entry 2 Bonello William · CIK 0001454941 · President, Informatics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,727 Underlying: Common Stock · 25,000 shares Expires 2022-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On April 28, 2017, Mr. Bonello was granted 100,000 stock options. These options vested ratably over the first three anniversary dates of the grant date. Read SEC document |
| November 30, 2021 Filed Dec 2, 2021 23:09 UTC |
Bonello WilliamPresident, Informatics
|
Exercise / conversionCommon Stock | 25,000 | $7.52 | $188,000.00 |
DisclosureSEC source: 0001077183-21-000254 · wf-form4_163848655622024.xml · nonDerivative · entry 1 Bonello William · CIK 0001454941 · President, Informatics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,473 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 26, 2021 Filed Nov 26, 2021 21:14 UTC |
Brown Douglas MatthewChief Strategy Officer
|
SaleCommon Stock | 33,334 | $36.85 | $1,228,357.90 |
DisclosureSEC source: 0001077183-21-000249 · wf-form4_163796128276463.xml · nonDerivative · entry 3 Brown Douglas Matthew · CIK 0001849414 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,644 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| November 24, 2021 Filed Nov 26, 2021 21:14 UTC |
Brown Douglas MatthewChief Strategy Officer
|
SaleCommon Stock | 33,333 | $36.84 | $1,227,987.72 |
DisclosureSEC source: 0001077183-21-000249 · wf-form4_163796128276463.xml · nonDerivative · entry 2 Brown Douglas Matthew · CIK 0001849414 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,978 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| November 24, 2021 Filed Nov 29, 2021 21:16 UTC |
Bonello WilliamPresident, Informatics
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $8.03 | $0.00 |
DisclosureSEC source: 0001077183-21-000251 · wf-form4_163822054448872.xml · derivative · entry 4 Bonello William · CIK 0001454941 · President, Informatics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,370 Underlying: Common Stock · 25,000 shares Expires 2023-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · derivative.exercise_date: On February 26, 2018, Mr. Bonello was granted 120,500 stock options. These options vested ratably over the first three anniversary dates of the grant date. Read SEC document |
| November 24, 2021 Filed Nov 29, 2021 21:16 UTC |
Bonello WilliamPresident, Informatics
|
SaleCommon Stock | 25,000 | $37.13 | $928,250.00 |
DisclosureSEC source: 0001077183-21-000251 · wf-form4_163822054448872.xml · nonDerivative · entry 2 Bonello William · CIK 0001454941 · President, Informatics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,473 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| November 24, 2021 Filed Nov 29, 2021 21:16 UTC |
Bonello WilliamPresident, Informatics
|
Exercise / conversionCommon Stock | 25,000 | $8.03 | $200,750.00 |
DisclosureSEC source: 0001077183-21-000251 · wf-form4_163822054448872.xml · nonDerivative · entry 1 Bonello William · CIK 0001454941 · President, Informatics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,473 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| November 23, 2021 Filed Nov 26, 2021 21:14 UTC |
Brown Douglas MatthewChief Strategy Officer
|
SaleCommon Stock | 33,333 | $37.19 | $1,239,654.27 |
DisclosureSEC source: 0001077183-21-000249 · wf-form4_163796128276463.xml · nonDerivative · entry 1 Brown Douglas Matthew · CIK 0001849414 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,311 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| November 10, 2021 Filed Nov 12, 2021 22:19 UTC |
Daly DavidDirector
|
GrantStock Option (Right to Buy) · Derivative | 1,945 | $0.00 Strike: $43.39 | $0.00 |
DisclosureSEC source: 0001077183-21-000247 · wf-form4_163675554239042.xml · derivative · entry 2 Daly David · CIK 0001320267 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,945 Underlying: Common Stock · 1,945 shares Expires 2028-06-02 Read SEC document |
| November 10, 2021 Filed Nov 12, 2021 22:19 UTC |
Daly DavidDirector
|
GrantCommon Stock | 1,623 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-21-000247 · wf-form4_163675554239042.xml · nonDerivative · entry 1 Daly David · CIK 0001320267 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,623 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.